Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- befree-2016 importedOn "2016-02-19" NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_assertion wasGeneratedBy ECO_0000203 NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_assertion wasDerivedFrom befree-2016 NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_assertion SIO_000772 15548710 NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_assertion evidence source_evidence_literature NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.
- NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_assertion description "[Thus, inhibition of PI3K activity with concomitant administration of chemotoxic compounds may prove beneficial in preventing the development of drug resistance in patients with hormone-refractory prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469429.RAb9CrzKRorrdOl4aU37hnh_yF_QcLLSloiZWxgFY7HDU130_provenance.